Rochlin Kate has filed 16 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 80000 shares of IN8BIO, INC. ($INAB) on February 04, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 4, 2026 | IN8BIO, INC. | $INAB | Rochlin Kate | President and COO | A | Employee Stock Option (right to buy) | 80000 | $0.00 | 80,000.0000 | 4,589,196 | 9999.99% | 1.74% |
| Dec. 22, 2025 | IN8BIO, INC. | $INAB | Rochlin Kate | Chief Operating Officer | A | Common Stock | 7247 | $1.38 | 9,085.0000 | 4,589,196 | 394.29% | 0.16% |
| April 27, 2025 | IN8BIO, INC. | $INAB | Rochlin Kate | Chief Operating Officer | A | Series A Warrants (right to buy) | 12295 | $0.00 | 12,295.0000 | 72,483,253 | 9999.99% | 0.02% |
| April 30, 2025 | IN8BIO, INC. | $INAB | Rochlin Kate | Chief Operating Officer | M | Series A Warrants (right to buy) | 12295 | $0.00 | 0.0000 | 72,483,253 | 100.00% | 0.02% |
| April 27, 2025 | IN8BIO, INC. | $INAB | Rochlin Kate | Chief Operating Officer | D | Series B Warrants (right to buy) | 12295 | $0.00 | 0.0000 | 72,483,253 | 100.00% | 0.02% |
| April 27, 2025 | IN8BIO, INC. | $INAB | Rochlin Kate | Chief Operating Officer | A | Series B Warrants (right to buy) | 12295 | $0.00 | 12,295.0000 | 72,483,253 | 9999.99% | 0.02% |
| April 30, 2025 | IN8BIO, INC. | $INAB | Rochlin Kate | Chief Operating Officer | M | Common Stock | 12295 | $0.18 | 55,169.0000 | 72,483,253 | 28.68% | 0.02% |
| April 27, 2025 | IN8BIO, INC. | $INAB | Rochlin Kate | Chief Operating Officer | D | Series A Warrants (right to buy) | 12295 | $0.00 | 0.0000 | 72,483,253 | 100.00% | 0.02% |
| Feb. 5, 2025 | IN8BIO, INC. | $INAB | Rochlin Kate | Chief Operating Officer | A | Employee Stock Option (right to buy) | 338950 | $0.00 | 338,950.0000 | 72,483,253 | 9999.99% | 0.47% |
| Dec. 19, 2024 | IN8BIO, INC. | $INAB | Rochlin Kate | Chief Operating Officer | A | Employee Stock Option (right to buy) | 302839 | $0.00 | 302,839.0000 | 43,287,325 | 9999.99% | 0.70% |
| Oct. 4, 2024 | IN8BIO, INC. | $INAB | Rochlin Kate | Chief Operating Officer | A | Series A Warrants (right to buy) | 12295 | $0.00 | 12,295.0000 | 43,287,325 | 9999.99% | 0.03% |
| Oct. 4, 2024 | IN8BIO, INC. | $INAB | Rochlin Kate | Chief Operating Officer | A | Series C Warrants (right to buy) | 25316 | $0.00 | 25,316.0000 | 43,287,325 | 9999.99% | 0.06% |
| Oct. 4, 2024 | IN8BIO, INC. | $INAB | Rochlin Kate | Chief Operating Officer | A | Common Stock | 25316 | $0.00 | 42,874.0000 | 43,287,325 | 144.19% | 0.06% |
| Oct. 4, 2024 | IN8BIO, INC. | $INAB | Rochlin Kate | Chief Operating Officer | D | Series A Warrants (right to buy) | 12295 | $0.00 | 0.0000 | 43,287,325 | 100.00% | 0.03% |
| Sept. 4, 2024 | IN8BIO, INC. | $INAB | Rochlin Kate | Chief Operating Officer | A | Employee Stock Option (right to buy) | 250000 | $0.00 | 250,000.0000 | 43,287,325 | 9999.99% | 0.58% |
| Feb. 7, 2024 | IN8BIO, INC. | $INAB | Rochlin Kate | CHIEF OPERATING OFFICER | A | Employee Stock Option (right to buy) | 186000 | $0.00 | 186,000.0000 | 43,287,325 | 9999.99% | 0.43% |